Gujarat Themis Biosyn P/B Ratio
Gujarat Themis Biosyn P/B ratio. Gujarat Themis Biosyn (GUJTHEM) P/B ratio is 6.66 (High), book value per share ₹261.82 vs Healthcare average P/B of 0.01 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see GUJTHEM share price.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
GUJTHEM P/B Ratio — Valuation Insights & Book Value Analysis
Gujarat Themis Biosyn price-to-book ratio interpretation, valuation status and historical context — current P/B 6.66 (High). View GUJTHEM 52-week high low for the annual high/low range and current price position.
- Stock appears overvalued with PB of 6.66, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 459.7% above historical average
- Trading at premium to sector average PB of 0.01
Gujarat Themis Biosyn P/B Ratio Historical Trend
GUJTHEM annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Analyse GUJTHEM FII DII holdings to track promoter, FII and institutional holdings.
GUJTHEM Historical P/B Ratio — Book Value Per Share & Year-End Price
Gujarat Themis Biosyn annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.43 | ₹261.82 | ₹373.60 | ₹288 | Moderate |
| 2025 | 1.96 | ₹225.45 | ₹441.65 | ₹248 | Moderate |
| 2024 | 1.06 | ₹287.14 | ₹305.45 | ₹201 | Moderate |
| 2023 | 0.8 | ₹212.86 | ₹171.05 | ₹149 | Low |
| 2022 | 0.7 | ₹147.14 | ₹103.15 | ₹103 | Low |
GUJTHEM vs Healthcare Peers — P/B Ratio Comparison
Gujarat Themis Biosyn P/B 6.66 vs Healthcare average 0.01, median 0.65 — range -6.55–1.13.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹47 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |